Literature DB >> 16887816

Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity.

Rie Matsushima1, Nagakatsu Harada, Nicholas J G Webster, Yasuo M Tsutsumi, Yutaka Nakaya.   

Abstract

Insulin and nutrients activate hepatic p70 S6 kinase (S6K1) to regulate protein synthesis. Paradoxically, activation of S6K1 also leads to the development of insulin resistance. In this study, we investigated the effect of TRB3, which acts as an endogenous inhibitor of Akt, on S6K1 activity in vitro and in vivo. In cultured cells, overexpression of TRB3 completely inhibited insulin-stimulated S6K1 activation by mammalian target of rapamycin, whereas knockdown of endogenous TRB3 increased both basal and insulin-stimulated activity. In C57BL/6 mice, adenoviral overexpression of TRB3 inhibited insulin-stimulated activation of hepatic S6K1. In contrast, overexpression of TRB3 did not inhibit nutrient-stimulated S6K1 activity. We also investigated the effect of starvation, feeding, or insulin treatment on TRB3 levels and S6K1 activity in the liver of C57BL/6 and db/db mice. Both insulin and feeding activate S6K1 in db/db mice, but only insulin activates in the C57BL/6 strain. TRB3 levels were 3.5-fold higher in db/db mice than C57BL/6 mice and were unresponsive to feeding or insulin, whereas both treatments reduced TRB3 in C57BL/6 mice. Akt was activated by insulin alone in the C57BL/6 strain and but not in db/db mice. Both insulin and feeding activated mammalian target of rapamycin similarly in these mice; however, feeding was unable to activate the downstream target S6K1 in C57BL/6 mice. These results suggest that the nutrient excess in the hyperphagic, hyperinsulinemic db/db mouse primes the hepatocyte to respond to nutrients resulting in elevated S6K1 activity. The combination of elevated TRB3 and constitutive S6K1 activity results in decreased insulin signaling via the IRS-1/phosphatidylinositol 3-kinase/Akt pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887816     DOI: 10.1074/jbc.M511636200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  TRB3 blocks adipocyte differentiation through the inhibition of C/EBPbeta transcriptional activity.

Authors:  Olivier Bezy; Cecile Vernochet; Stephane Gesta; Stephen R Farmer; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2007-07-23       Impact factor: 4.272

2.  Differential effects of intrauterine growth restriction and a hypersinsulinemic-isoglycemic clamp on metabolic pathways and insulin action in the fetal liver.

Authors:  Amanda K Jones; Laura D Brown; Paul J Rozance; Natalie J Serkova; William W Hay; Jacob E Friedman; Stephanie R Wesolowski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-13       Impact factor: 3.619

3.  Translational control during endoplasmic reticulum stress beyond phosphorylation of the translation initiation factor eIF2α.

Authors:  Bo-Jhih Guan; Dawid Krokowski; Mithu Majumder; Christine L Schmotzer; Scot R Kimball; William C Merrick; Antonis E Koromilas; Maria Hatzoglou
Journal:  J Biol Chem       Date:  2014-03-19       Impact factor: 5.157

Review 4.  Insulin receptor signaling in normal and insulin-resistant states.

Authors:  Jérémie Boucher; André Kleinridders; C Ronald Kahn
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

5.  Association of TRB3 gene Q84R polymorphism with type 2 diabetes mellitus in Chinese population.

Authors:  Zhiyong Shi; Jing Liu; Qian Guo; Xiaoqin Ma; Linna Shen; Sanni Xu; Hongxia Gao; Xinjian Yuan; Junling Zhang
Journal:  Endocrine       Date:  2009-03-17       Impact factor: 3.633

6.  Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis.

Authors:  John D Cravero; Cathy S Carlson; Hee-Jeong Im; Raghunatha R Yammani; David Long; Richard F Loeser
Journal:  Arthritis Rheum       Date:  2009-02

7.  Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.

Authors:  Hongliang Li; Mingjiang Xu; Jiyeon Lee; Chaoyong He; Zhonglin Xie
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-11       Impact factor: 4.310

8.  Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis.

Authors:  Scot R Kimball; A N Dang Do; Lydia Kutzler; Douglas R Cavener; Leonard S Jefferson
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

9.  Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease.

Authors:  Yu-Gang Wang; Min Shi; Ting Wang; Ting Shi; Jue Wei; Na Wang; Xi-Mei Chen
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

10.  Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.

Authors:  N Miyoshi; H Ishii; K Mimori; Y Takatsuno; H Kim; H Hirose; M Sekimoto; Y Doki; M Mori
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.